Biotech+ Hub at Pegasus Park reposted this
Congratulations to Vinny Jindal and the Secretome Therapeutics team! 👏👏👏 #LifeScienceDFW #innovation
The capital raised in this round will support operations through mid-2026 and fund key initiatives, including: Clinical Trials: Launching two Phase 1 trials of STM-01 in HFpEF (heart failure with preserved ejection fraction) and DCM (dilated cardiomyopathy), with proof-of-concept data expected in Q3 2025. Manufacturing Scale-Up: Transitioning STM-01 manufacturing to 3-dimensional bioreactor technology. Pipeline Development: Advancing STM-21 and other preclinical programs to address inflammatory conditions. Regulatory Engagement: Defining the regulatory pathway for STM-01 in orphan indications. Intellectual Property: Submitting patents on next-generation cell and secretome products following the issuance of composition patents for STM-01 and STM-21.